
Medically Reviewed By
Dr. Neha Gupta ( Medical Oncology)
Comprehensive clinical guide to Lymphoma Treatment authored by Dr. Neha Gupta at Spica Healthcare β Grover Hospital, Bathinda. Learn about indications, surgical pathways, recovery timelines, and 100% cashless PM-JAY Ayushman Bharat coverage.
Lymphoma Treatment represents a cornerstone clinical program at Spica Healthcare β Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.
In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.
β’ Biopsy-confirmed Hodgkin Lymphoma or Non-Hodgkin Lymphoma (DLBCL, Follicular, Mantle Cell, Burkitt).
β’ Painless enlarged lymph nodes in the neck, axilla, or groin persisting longer than 2 to 3 weeks.
β’ Patients with unexplained drenching night sweats, intermittent fevers, and significant weight loss.
β’ Relapsed or refractory lymphoma requiring second-line targeted antibody-drug conjugates or BTK inhibitors.
Excisional lymph node biopsy with comprehensive IHC panel (CD20, CD30, CD3, CD5, Ki-67) and whole-body PET-CT.
Personalized selection of immunochemotherapy regimen (Pola-R-CHP, R-CHOP, AVD-Brentuximab) by Dr. Neha Gupta.
Outpatient daycare infusions with anti-emetic coverage, tumor lysis prophylaxis, and growth factor support.
Interim and post-treatment FDG PET-CT verification documenting sustained complete metabolic remission.
Dr. Neha Gupta delivers precision targeted immunochemotherapy for Hodgkin Lymphoma (HL) and Non-Hodgkin Lymphoma (NHL, including Diffuse Large B-Cell Lymphoma - DLBCL, Follicular, Mantle Cell, and T-cell lymphomas). Utilizing upfront CD20/CD30/CD19 immunophenotyping, interim FDG PET-CT Deauville scoring to guide response-adapted therapy, antibody-drug conjugates (Brentuximab Vedotin, Polatuzumab Vedotin - POLARIX protocol), and oral BTK inhibitors (Ibrutinib, Acalabrutinib), overall cure rates exceed 85β90% in Hodgkin Lymphoma and DLBCL with minimal long-term toxicity.
β PET-Adapted Therapy (Deauville Score): Modulates chemo intensity based on interim PET response to avoid toxicity
β POLARIX Protocol (Pola-R-CHP): Antibody-drug conjugate combination improving progression-free survival in DLBCL
β Brentuximab Vedotin Integration: CD30-targeted ADC delivering high cure rates in advanced Hodgkin Lymphoma
β Oral BTK & BCL-2 Inhibitors: Chemotherapy-free targeted oral tablets for Mantle Cell, CLL, and Marginal Zone lymphomas
Excisional lymph node biopsy review, whole-body FDG PET-CT scan, bone marrow biopsy, Chemoport placement.
Targeted immunochemotherapy cycles (R-CHOP / Pola-R-CHP / ABVD) administered in Daycare suite.
Interim PET-CT scan (Deauville scoring) assessing early complete metabolic clearance.
End-of-treatment PET-CT confirming complete cure; structured 3-monthly survivorship follow-up.
Lymphomas are divided into Hodgkin Lymphoma (characterized by Reed-Sternberg cells under microscope) and Non-Hodgkin Lymphoma (NHL, which includes B-cell and T-cell subtypes like DLBCL and Follicular). Both are among the most treatable and curable of all cancers when targeted immunochemotherapy is administered on time.
The most common early sign is one or more painless, rubbery swellings (enlarged lymph nodes) in the neck, armpits, or groin. Other common 'B-symptoms' include drenching night sweats that soak sheets, unexplained fever, and losing more than 10% of body weight in 6 months.
Yes, lymphoma diagnostics, whole-body PET-CT scans, immunochemotherapy infusions, monoclonal antibodies (Rituximab), and daycare admissions at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.
At Spica Healthcare β Grover Hospital Bathinda, Lymphoma Treatment is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.

Senior Consultant & Clinical Director β Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi

13+ Years Experience
Spica β Grover Hospital
Request a priority OPD appointment or second opinion on your scans.
Proprietary surgical methodologies and precision protocols pioneered by our senior directors to minimize trauma, protect natural anatomy, and accelerate recovery.

Dr. Deepak Garg (Orthopaedic Surgical Oncology - RGCI Delhi Trained) and Dr. Neha Gupta (Medical Oncology) co-lead the Bone Cancer & Sarcoma Center at Spica Healthcare. Integrating intensive multi-agent neoadjuvant chemotherapy protocols (MAP: High-Dose Methotrexate, Doxorubicin, Cisplatin for Osteosarcoma; VIDE: Vincristine, Ifosfamide, Doxorubicin, Etoposide for Ewing Sarcoma) with 3D computer-navigated limb salvage surgery and modular titanium megaprosthetic joint reconstruction, 5-year survival rates exceed 75% to 80% while saving over 95% of patients from limb amputation.
Spica Healthcare β Bone and Cancer Institute, Bathinda β is South-Western Punjab's premier super-speciality centre led by AIIMS and Tata Memorial fellowship-trained directors.
Every diagnostic MRI review, surgical staging, and operation is personally directed by chief clinical specialists β Dr. Deepak Garg (Orthopaedic Oncology & Robotics) and Dr. Neha Gupta (Medical Oncology) β guaranteeing zero junior proxies.
Sub-millimeter implant positioning and soft-tissue ligament balancing ensuring patients walk comfortably within 24 hours of total knee replacement.
South-West Punjab's only dedicated centre for modular titanium megaprosthesis, saving natural limbs and functions in 95%+ of bone cancer patients.
Full cashless coverage for Ayushman Bharat (PM-JAY), Punjab Govt Health Schemes, ECHS, and 30+ private insurance networks with on-desk approvals.
Positive-pressure HEPA filtered theatres minimizing infection rates below international benchmarks with 24/7 dedicated critical care backup.
Fellowship-trained surgical directors from AIIMS & Tata Memorial providing compassionate, world-class tertiary care in super-speciality orthopaedics and medical oncology.

Senior Consultant & Clinical Director β Medical Oncology
MBBS (BFUHS Faridkot), MD Radiation Oncology (BFUHS Faridkot), DrNB Medical Oncology (Sarvodaya Hospital, Faridabad), Precision Oncology (Harvard, USA), Ex Consultant RGCI New Delhi


Senior Consultant & Clinical Director β Orthopaedic Oncology & Robotic Joint Surgery
16+ Yrs ExpSenior Consultant & Clinical Director β Orthopaedic Oncology & Robotic Joint Surgery
MBBS (TNMC Mumbai), DNB Orthopaedics (PGI & SP Miraj), Fellowship Arthroplasty and Arthroscopy (Fortis Hospital, New Delhi), Fellowship Orthopaedic Oncology (Rajiv Gandhi Cancer Institute, New Delhi)
Free OPD screening camps, director-led masterclasses, and national oncology representations by Spica Healthcare.
Real stories from patients who recovered through limb preservation surgery, 3D robotic joint replacements, and precision cancer care at Spica Healthcare β Grover Hospital, Bathinda.
Evidence-based surgical recovery roadmaps, robotic joint protocols, and precision oncology insights written by our clinical directors.